Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,647 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors.
Hatta K, Kishi Y, Wada K, Takeuchi T, Hashimoto N, Suda K, Taira T, Tsuchida K, Ohmori T, Akizuki N, Nishio Y, Nakanishi Y, Usui C, Kurata A, Horikawa N, Eguchi H, Ito S, Muto H, Nakamura H, Uchimura N. Hatta K, et al. Among authors: eguchi h. J Clin Psychiatry. 2019 Dec 17;81(1):19m12865. doi: 10.4088/JCP.19m12865. J Clin Psychiatry. 2019. PMID: 31851436 Free article. Clinical Trial.
Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs.
Kimura K, Inoue Y, Asari S, Sunada A, Ohashi Y, Shimomura Y, Sotozono C, Hatano H, Fukuda M, Eguchi H, Araki-Sasaki K, Suzuki T, Hoshi S, Tobe T, Yaguchi T, Makimura K; Multicenter Study Group of Fungal Keratitis in Japan. Kimura K, et al. Among authors: eguchi h. Jpn J Ophthalmol. 2022 May;66(3):240-253. doi: 10.1007/s10384-022-00907-2. Epub 2022 Mar 29. Jpn J Ophthalmol. 2022. PMID: 35348983
Effect of immortal time bias on the association between immune-related adverse events and oncological outcomes following immune checkpoint inhibitors therapy for head and neck squamous cell carcinoma.
Tamura K, Takenaka Y, Hosokawa K, Sato T, Tsuda T, Eguchi H, Suzuki M, Fukusumi T, Suzuki M, Inohara H. Tamura K, et al. Among authors: eguchi h. PLoS One. 2024 Nov 25;19(11):e0314209. doi: 10.1371/journal.pone.0314209. eCollection 2024. PLoS One. 2024. PMID: 39585818 Free PMC article.
1,647 results